Advancing Healthcare Innovation Through CI 360
Through the Corporate Innovation 360 (CI 360) program, Novartis Egypt is addressing key healthcare challenges by integrating scalable digital solutions and fostering innovation across the healthcare ecosystem. From outdated medical record systems to fragmented patient engagement channels and inefficient HCP data strategies, Novartis collaborated with startups to co-create tech-driven tools and enhance operational efficiency.
By leveraging CI 360’s Open Innovation track, Novartis identified and supported startups offering plug-and-play EMR systems, digital companions, and advanced HCP analytics—paving the way for improved healthcare delivery and measurable impact.
Discover how Novartis Egypt is accelerating digital transformation through strategic startup collaboration.
Joint Innovation Priorities of Novartis Egypt & CI 360:
Transforming Healthcare with Novartis Egypt & CI 360
Case Study: Optimizing HCP Engagement and Investment Allocation
Description: Limitless Care, in collaboration with Novartis Egypt, tackled the challenge of adapting HCP engagement strategies and resource allocation amid evolving external factors. Their solution anticipates the impact of these changes on sales progress, enabling better targeting, improved ROI, and more effective sales planning. By supporting pharma companies with actionable insights, Limitless Care is driving smarter engagement and more personalized patient support.
Case Study: Simplifying EMR Implementation in Healthcare Facilities
Description: Ayamedica joined forces with Novartis Egypt to address the pressing need for scalable EMR systems. Their innovative solution enables quick digitization of medical records across hospitals, clinics, and school facilities, enhancing data access and patient care. With an intuitive interface and patient-provider communication tools, Ayamedica is transforming how healthcare data is managed—supporting Novartis mission to enable smarter, data-driven healthcare in Egypt.
Techne © 2026 All rights reserved.